Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas

References

• StrongVED’AmicoTAKleinbergLAjaniJImpact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancersJ Natl Compr Canc Netw2013111606623307982
   PubMed Web of Science ®Google Scholar
• ZhangXFHuangCMLuHSSurgical treatment and prognosis of gastric cancer in 2,613 patientsWorld J Gastroenterol200410233405340815526356
   PubMed Web of Science ®Google Scholar
• SakuramotoSSasakoMYamaguchiTACTS-GC GroupAdjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidineN Engl J Med2007357181810182017978289
   PubMed Web of Science ®Google Scholar
• WalkerRAThe erbB/HER type 1 tyrosine kinase receptor familyJ Pathol199818532342359771475
   PubMed Web of Science ®Google Scholar
• OlayioyeMANeveRMLaneHAHynesNEThe ErbB signaling network: receptor heterodimerization in development and cancerEMBO J200019133159316710880430
   PubMed Web of Science ®Google Scholar
• CasaliniPIorioMVGalmozziEMénardSRole of HER receptors family in development and differentiationJ Cell Physiol2004200334335015254961
   PubMed Web of Science ®Google Scholar
• SerginaNVMoasserMMThe HER family and cancer: emerging molecular mechanisms and therapeutic targetsTrends Mol Med2007131252753417981505
   PubMed Web of Science ®Google Scholar
• YkWCfGTYAssessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridizationMol Cytogenet2011411421689422
   PubMed Web of Science ®Google Scholar
• HayashiMInokuchiMTakagiYHigh expression of HER3 is associated with a decreased survival in gastric cancerClin Cancer Res200814237843784919047113
   PubMed Web of Science ®Google Scholar
• BegnamiMDFukudaEFregnaniJHPrognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcomeJ Clin Oncol201129223030303621709195
   PubMed Web of Science ®Google Scholar
• TerashimaMKitadaKOchiaiAImpact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancerClin Cancer Res201218215992600022977193
   PubMed Web of Science ®Google Scholar
• LaurénPThe two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classificationActa Pathol Microbiol Scand196564314914320675
   PubMedGoogle Scholar
• AhnHSLeeHJHahnSEvaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classificationCancer2010116245592559820737569
   PubMed Web of Science ®Google Scholar
• RobinsonKWSandlerABEGFR tyrosine kinase inhibitors: difference in efficacy and resistanceCurr Oncol Rep201315439640423674236
   PubMed Web of Science ®Google Scholar
• KearsleyJHLeonardJHWalshMDWrightGRA comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomasPathology19912331891941685773
   PubMed Web of Science ®Google Scholar
• BoninSLissianiAMaffezziniMStantaGEGFr and c-erB2mRNA expression in urinary bladder superficial carcinomasAdv Clin Path199712155159
   Google Scholar
• OvermanMJHoffPMEGFR-targeted therapies in colorectal cancerDis Colon Rectum20075081259127017566832
   PubMed Web of Science ®Google Scholar
• VranicSTawfikOPalazzoJEGFR and HER-2/neu expression in invasive apocrine carcinoma of the breastMod Pathol201023564465320208479
   PubMed Web of Science ®Google Scholar
• YoshidaKKyoETsudaTEGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factorsInt J Cancer19904511311352298497
   PubMed Web of Science ®Google Scholar
• KimMALeeHSLeeHEJeonYKYangHKKimWHEGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy numberHistopathology200852673874618397279
   PubMed Web of Science ®Google Scholar
• NagatsumaAKAizawaMKuwataTExpression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinomaGastric Cancer Epub2014314
   Google Scholar
• Di FioreFSesboüéRMichelPSabourinJCFrebourgTMolecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancerBr J Cancer2010103121765177221139621
   PubMed Web of Science ®Google Scholar
• FukushigeSMatsubaraKYoshidaMLocalization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell lineMol Cell Biol1986639559582430175
   PubMed Web of Science ®Google Scholar
• GravalosCJimenoAHER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnn Oncol20081991523152918441328
   PubMed Web of Science ®Google Scholar
• GarcíaIVizosoFMartínAClinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancerAnn Surg Oncol200310323424112679307
   PubMed Web of Science ®Google Scholar
• BangYJVan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialLancet2010376974268769720728210
   PubMed Web of Science ®Google Scholar
• SternHMImproving treatment of HER2-positive cancers: opportunities and challengesSci Transl Med20124127127rv2
   Web of Science ®Google Scholar
• GravalosCJimenoAHER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnn Oncol20081991523152918441328
   PubMed Web of Science ®Google Scholar
• XuRHOiuMZZhouYXThe relationship between HER2 expression and Lauren classification in Chinese gastric cancer patientsJ Clin Oncol2014325s abstract 4065
   Google Scholar
• ChuaTCMerrettNDClinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes – a systematic reviewInt J Cancer2012130122845285621780108
   PubMed Web of Science ®Google Scholar
• LédelFHallströmMRagnhammarPÖhrlingKEdlerDHER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcomeEur J Cancer201450365666224300455
   PubMed Web of Science ®Google Scholar
• HinoharaKKobayashiSKanauchiHErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancerProc Natl Acad Sci U S A2012109176584658922492965
   PubMed Web of Science ®Google Scholar
• WeiQShengLShuiYHuQNordgrenHCarlssonJEGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastasesAnn Surg Oncol20081541193120118172732
   PubMed Web of Science ®Google Scholar
• YoonHHSukovWRShiQHER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinomaCancer2014120341542424151090
   PubMed Web of Science ®Google Scholar
• HsiehACMoasserMMTargeting HER proteins in cancer therapy and the role of the non-target HER3Br J Cancer200797445345717667926
   PubMed Web of Science ®Google Scholar
• van der HorstEHMurgiaMTrederMUllrichAAnti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodiesInt J Cancer2005115451952715704104
   PubMed Web of Science ®Google Scholar
• BaselgaJSwainSMNovel anticancer targets: revisiting ERBB2 and discovering ERBB3Nat Rev Cancer20099746347519536107
   PubMed Web of Science ®Google Scholar